Results 191 to 200 of about 28,830 (248)

Advancing Research on Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Scientometric Analysis. [PDF]

open access: yesMalays J Med Sci
Matin A   +5 more
europepmc   +1 more source

Retraction Note: Potential use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition and prevention method in viral infection. [PDF]

open access: yesMicrob Cell Fact
Muzammil K   +7 more
europepmc   +1 more source

Anti-inflammatory effects of proprotein convertase subtilisin/kexin 9 inhibitor therapy in the early phase of acute myocardial infarction. [PDF]

open access: yesHeart Vessels
Shimizu T   +12 more
europepmc   +1 more source

Cholesteryl Ester Species but Not Serum Proprotein Convertase Subtilisin/Kexin Type 9 Levels Decline in Male Patients with Active Inflammatory Bowel Disease. [PDF]

open access: yesPathophysiology
Hettenbach A   +9 more
europepmc   +1 more source

Novel insights into the association between genetically proxied inhibition of proprotein convertase subtilisin/kexin type 9 and risk of sarcopenia. [PDF]

open access: yesJ Cachexia Sarcopenia Muscle
Jiang H   +12 more
europepmc   +1 more source

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Improves the Vascular Function of Arteriovenous Fistula in Rats with Hyperglycemia. [PDF]

open access: yesActa Cardiol Sin
Wang YC   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy